CandidPharm · Ningbo Candid Pharmaceutical Co., Ltd. · 宁波嘉安药业有限公司
CATEGORY B · CP-SGLT-01Intermediate

2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone

2,3,4,6-四-O-三甲基硅基-D-葡萄糖酸内酯
CAS Registry No.
32384-65-9
Related API
Canagliflozin/Dapagliflozin/Empagliflozin
Molecular Weight
466.9
Product Type
Intermediate

Identification & Structure

Chemical structure of 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone
2D Structure

C[Si](C)(C)OC[C@@H]1[C@H]([C@@H]([C@H](C(=O)O1)O[Si](C)(C)C)O[Si](C)(C)C)O[Si](C)(C)C

Product CodeCP-SGLT-01
Product TypeIntermediate
CAS Number32384-65-9
Molecular FormulaC18H42O6Si4
Molecular Weight466.9
IUPAC Name(3R,4S,5R,6R)-3,4,5-tris(trimethylsilyloxy)-6-(trimethylsilyloxymethyl)oxan-2-one
SMILESC[Si](C)(C)OC[C@@H]1[C@H]([C@@H]([C@H](C(=O)O1)O[Si](C)(C)C)O[Si](C)(C)C)O[Si](C)(C)C
InChIKeyVNGTZLYNGGLPIZ-WCXIOVBPSA-N
PubChem CID10994280
Quality ParametersRequest current specification and available batch documentation

Related API

Listed in our catalog as an intermediate related to Canagliflozin/Dapagliflozin/Empagliflozin.

Specifications and available documentation are reviewed against your project requirements. Availability and lead time are confirmed for each enquiry, taking current stock and production schedules into account.

Direct Inquiries

Request a Quote & Documents

Tell us the quantity, specification and destination. We will reply by email with pricing, lead time and the documents available.

· We will reply by email
· Mutual NDA available on request

Documents on Request

Request current specification and available batch documentation. We will confirm which TDS, SDS, CoA and analytical materials can be shared for this product.

Patent Notice

Supply is reviewed against the destination, patent status and intended use. Products are not offered where the transaction would infringe valid patents or supplementary protection certificates. Where applicable, regulatory-development activities may fall within the Bolar exemption under Article 10(6) of EU Directive 2001/83/EC, as amended by Directive 2004/27/EC, or 35 U.S.C. § 271(e)(1). These provisions have specific conditions; research use alone does not establish an exemption. Buyers must confirm applicable requirements for their jurisdiction and project before ordering. Commercial supply in protected territories requires an applicable legal basis.

Product-specific evaluation

Protected sugar building block

  • Confirm protected-sugar identity and stereochemical assignment.
  • Discuss water sensitivity, handling and applicable impurity methods.
TDS
Availability to be confirmed
SDS
Availability to be confirmed
Batch CoA
Availability to be confirmed
Analytical evidence
Availability to be confirmed

These are evaluation topics, not approved specifications. Request the current documents for this material. Sample batch, quantity and delivery arrangements are confirmed for your request.